UEL Tenant Highlight: Xenamed
Xenamed is a pharmaceutical drug development company founded in 2016. Xenamed develops products at UEL and collaborates with contract...
Regenerative Medicine Startup Peytant Solutions, Inc. “Graduates” from UEL, Receives $100k Biobusine
Peytant Solutions, Inc., headed by CEO John Schorgl, is committed to improving quality of life for patients worldwide by utilizing...
LiteRun adds financing
Lite Run Inc. is pleased to announce that it has won a $100,000 Small Business Innovation Research (SBIR) grant from the National...
CoreBiome: MicroBiome "Profiling" Services
Less than two months after raising $800,000 in a seed financing round, University of Minnesota spinoff CoreBiome Inc. officially...
